Gossamer Bio annual operating margin
2024
2025
Gossamer Bio's operating margin was −352.23% for fiscal 2025.
View full Gossamer Bio company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −352.23% | −299.99 pp |
| 2024 | 2024-12-31 | −52.24% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −282.25% | +55.16 pp |
| Q1 2026 | 2026-03-31 | −264.62% | +107.61 pp |
| Q4 2025 | 2025-12-31 | −333.64% | +51.56 pp |
| Q3 2025 | 2025-09-30 | −369.44% | −11.65 pp |
| Q2 2025 | 2025-06-30 | −337.41% | −391.76 pp |
| Q1 2025 | 2025-03-31 | −372.23% | — |
| Q4 2024 | 2024-12-31 | −385.20% | — |
| Q3 2024 | 2024-09-30 | −357.80% | — |
| Q2 2024 | 2024-06-30 | 54.35% | — |
Across the available reported history, Gossamer Bio's operating margin decreased from −52.24% to −352.23%, a change of −299.99 percentage points. The latest reported quarter, Q2 2026, shows −282.25%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gossamer Bio filings at SEC.gov ↗